Anti-SARS-CoV-2 neutralizing antibodies
US11359007B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2021 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | Aug 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides novel neutralizing antibodies against SARS-COV-2, and the antigen binding fragments thereof. Pharmaceutical composition and kits comprising the same, and the uses thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.